Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
Arno R BourgonjeAmarens van der VaartEke G GruppenHarry van GoorStephan J L BakkerMargery A ConnellyPeter R van DijkRobin P F DullaartPublished in: Endocrine (2023)
Higher plasma GlycA is associated with an increased risk of developing microvascular complications in T2D patients. Altered N-glycan branching associated with acute-phase reactive proteins may represent a preferred biomarker of systemic low-grade inflammation in predicting diabetic complications.